Literature DB >> 30878643

Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey.

Jubilee Brown1, Lane Drury2, Kyle Raub2, Barbara Levy3, Paula Brantner4, Thomas C Krivak5, Linda Bradley6, R Wendel Naumann2.   

Abstract

STUDY
OBJECTIVE: To characterize workplace and sexual harassment and discrimination among physicians in gynecology.
DESIGN: A beta-tested Internet survey was distributed by e-mail using the REDCap platform. All responses were anonymous.
SETTING: The survey was distributed to the 7026 physician members of an international gynecologic society (AAGL), including faculty and trainees. PATIENTS: Not applicable.
INTERVENTIONS: The survey was distributed on 3 occasions between July and September 2018. The survey contained questions on demographics, attitudes, experiences, and sequelae regarding harassment and discrimination in the workplace. Frequency distributions and nonparametric tests were performed to determine the percentages and types of harassment and discrimination among respondents.
MEASUREMENTS AND MAIN RESULTS: A total of 907 physicians responded, including 603 US physicians and 304 non-US physicians; 59% identified as female and 40% as male, and 20% were trainees. Females were more likely than males to think the #MeToo movement was "justified and overdue" (p < .05), independent of age or trainee status. More females than males reported experiencing workplace discrimination (67% vs 39%; p < .001); gender-based discrimination was the most common basis for both. Females indicated decreased self-confidence and lower salary; males indicated fewer employment opportunities and lower patient volume. Harassment was reported by more females than males (53% vs 17%; p < .001), including sexual harassment (39% vs 11%, p <.05). Most experienced loss of self-confidence, felt the offender was in a position of power, and did not report the incident, often due to fear of reprisal. Multiple respondents experienced workplace-related sexual assault.
CONCLUSION: Workplace harassment and discrimination are commonly experienced by female and male gynecologists and are usually related to a power differential. Improvements must be made in the workplace environment to achieve equity and a safe workplace free of harassment and discrimination.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  #MeToo; Discrimination; Harassment; Workplace

Mesh:

Year:  2019        PMID: 30878643     DOI: 10.1016/j.jmig.2019.03.004

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  6 in total

Review 1.  Improving Gender Diversity in Urologic Residency Training.

Authors:  Chideraa Ukeje; Ayman Elmasri; Stephanie Kielb
Journal:  Curr Urol Rep       Date:  2021-12-16       Impact factor: 3.092

2.  Patient Use of Physicians' First (Given) Name in Direct Patient Electronic Messaging.

Authors:  Jamison A Harvey; Richard J Butterfield; Shari A Ochoa; Yul W Yang
Journal:  JAMA Netw Open       Date:  2022-10-03

3.  Physicians' Experiences With Mistreatment and Discrimination by Patients, Families, and Visitors and Association With Burnout.

Authors:  Liselotte N Dyrbye; Colin P West; Christine A Sinsky; Mickey Trockel; Michael Tutty; Daniel Satele; Lindsey Carlasare; Tait Shanafelt
Journal:  JAMA Netw Open       Date:  2022-05-02

4.  Sexual harassment and gender discrimination in gynecologic oncology.

Authors:  Marina Stasenko; Christopher Tarney; Kenneth Seier; Yovanni Casablanca; Carol L Brown
Journal:  Gynecol Oncol       Date:  2020-08-22       Impact factor: 5.482

5.  Prevalence of gender-based and sexual harassment within orthopedic surgery in Canada.

Authors:  Victoria Giglio; Patricia Schneider; Zoe Bond; Kim Madden; Paula McKay; Anthony Bozzo; Mohit Bhandari; Michelle Ghert
Journal:  Can J Surg       Date:  2022-01-27       Impact factor: 2.089

6.  Gynecologic Oncology and Inclusion of Women Into the Surgical Workforce: The Canary in This Coal Mine.

Authors:  Linda J Hong; Lisa Rubinsak; Michelle F Benoit; Deanna Teoh; Uma Chandavarkar; Amy Brockmeyer; Erin Stevens; Yevgeniya Ioffe; Sarah M Temkin
Journal:  Front Oncol       Date:  2022-04-06       Impact factor: 5.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.